Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Imualfa 1.6mg Injection 1ml
Manufacturer/Marketed By : ALNICHE LIFE SCIENCES PVT LTD
$28.86 $24.54
Imualfa 1.6mg injection 1ml is an anti-cancer drug belonging to the class of synthetic thymic peptides containing the active ingredient Thymosin Alpha 1. This medication is an adjuvant therapy in...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
THYMOSIN ALPHA 1
Active Pharmaceutical Ingredient
Imualfa 1.6mg Injection 1ml
$28.86
$24.54
Imualfa 1.6mg injection 1ml is an anti-cancer drug belonging to the class of synthetic thymic peptides containing the active ingredient Thymosin Alpha 1. This medication is an adjuvant therapy in treating chronic hepatitis B and C. It is also used to treat acquired immunodeficiency syndrome(AIDS). This drug can also be used in the treatment of various types of cancer, as it can enhance the function of immune cells and promote tumor cell death. The safety of this drug during pregnancy and breastfeeding is unknown, and it is not recommended for use, so before planning for your pregnancy, please consult your doctor for more advice. This medicine may stimulate the immune system, exacerbating autoimmune diseases such as multiple sclerosis, lupus, or rheumatoid arthritis. Mainly, this drug should be used with caution in individuals with these conditions. This injection should not be used in individuals with allergies or known hypersensitivity to the medication or its components. Report to your doctor if you experience any reactions like itchy skin or rashes while taking this medicine. This drug is not recommended to individuals at increased risk of infections, such as those with a weakened immune system or those who have had recent surgery or invasive procedures, and they should be closely monitored for signs of infection while taking Imualfa 1.6mg injection 1ml. It is also important to note that this drug should not be used in immunocompromised patients or those with suppressed immunity, such as organ transplant patients, as it may increase the risk of infections.
Active Pharmaceutical Ingredient
Uses
• Hepatitis B & C
• HIV/AIDS
• Cancer (non-small cell lung cancer, liver cancer, melanoma)
Benefits
Imualfa 1.6mg injection 1ml works by stimulating the immune system and enhancing the production of certain immune cells, like T cells and natural killer cells, which can help the body fight off infections and cancer cells more effectively.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Fever
• Muscle ache
• Tiredness
• Nausea
• Vomiting
Common Side Effects
• Severe allergic reactions (difficulty in breathing or swallowing, swelling of hands, feet, lips, mouth, or throat, itchy rash)
• Pain at the site of injection (during or immediately after the injection)
How To Use
It should only be administered by a trained doctor or nurse experienced in chemotherapy. Imualfa 1.6mg injection 1ml is usually administered as a subcutaneous injection (under the skin). Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity and other factors.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Imualfa 1.6mg injection 1ml because there is no limited data on whether the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: Consuming alcohol may affect the effectiveness of the Imualfa 1.6mg injection 1ml. Stop consuming alcohol if you are taking this medicine.
• Liver: Inform your physician if you have liver problems before initiating the treatment with Imualfa 1.6mg injection 1ml.
• Lungs: It is unknown whether Imualfa 1.6mg injection 1ml can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Driving vehicles or operating heavy machinery is unsafe after taking Imualfa 1.6mg injection 1ml it may cause dizziness and impair concentration.
• Pregnancy: Imualfa 1.6mg injection 1ml is not recommended for pregnant women because there is no limited data on whether the medicine may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.